Somatic Systems Valuation
| SMAS Stock | USD 0.0001 0.00 0.00% |
Somatic Systems seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Somatic Systems from inspecting the company fundamentals such as Revenue of 107.42 K, shares outstanding of 14.6 B, and Profit Margin of (2.23) % as well as reviewing its technical indicators and probability of bankruptcy.
Enterprise Value 1.5 M | Price Sales 13.5898 |
Overvalued
Today
Please note that Somatic Systems' price fluctuation is very steady at this time. Calculation of the real value of Somatic Systems is based on 3 months time horizon. Increasing Somatic Systems' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Somatic stock is determined by what a typical buyer is willing to pay for full or partial control of Somatic Systems. Since Somatic Systems is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Somatic Stock. However, Somatic Systems' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Somatic Systems' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Somatic Systems' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Somatic Systems helps investors to forecast how Somatic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Somatic Systems more accurately as focusing exclusively on Somatic Systems' fundamentals will not take into account other important factors: Somatic Systems Cash |
|
About Somatic Systems Valuation
The stock valuation mechanism determines Somatic Systems' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Somatic Systems based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Somatic Systems. We calculate exposure to Somatic Systems's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Somatic Systems's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 87.9 K | 90.9 K |
Additional Tools for Somatic Stock Analysis
When running Somatic Systems' price analysis, check to measure Somatic Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Somatic Systems is operating at the current time. Most of Somatic Systems' value examination focuses on studying past and present price action to predict the probability of Somatic Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Somatic Systems' price. Additionally, you may evaluate how the addition of Somatic Systems to your portfolios can decrease your overall portfolio volatility.